eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | small cell carcinoma |
| Comorbidity | C0007131|non-small cell carcinoma of the lung |
| Sentences | 7 |
| PubMedID- 25699077 | In several cancer types, in particular breast, ovarian, gastric, and non-small cell carcinoma of the lung, amplification and/or overexpression of specific members of the erbb receptor family have been associated with poor clinical prognosis, including high incidence of metastasis and recurrence. |
| PubMedID- 21475657 | Past medical history was significant for stage iv non-small cell carcinoma of the lung diagnosed in aug 2005 and treated with left pneumonectomy. |
| PubMedID- 22957045 | From a clinical perspective, timp-1 is correlated with poor prognosis in several cancers including breast and colorectal tumors, as well as lymphoma and non-small cell carcinoma of the lung [8]. |
| PubMedID- 24288644 | Surgery is the major curative method for stage i non-small cell carcinoma of the lung; patients with late stage non-small cell carcinoma of the lung such as stage ii or higher are treated by combination therapy including postoperative radiotherapy, chemotherapy, or both. |
| PubMedID- 22958707 | Prognostic factors revealed by univariate and multivariate analyses in patients with completely resected non-small cell carcinoma of the lung (n = 98). |
| PubMedID- 24565030 | All patients had adenocarcinoma except for one who had poorly differentiated non-small cell carcinoma of the lung (3c). |
| PubMedID- 25807461 | Recently, plzf has been found to be down-regulated in non-small cell carcinoma of the lung [13], malignant mesothelioma [9] and malignant melanoma [8,10]. |
Page: 1